Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 18227842)

1.

The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.

Métais JY, Dunbar CE.

Mol Ther. 2008 Mar;16(3):439-49. doi: 10.1038/sj.mt.6300372. Epub 2008 Jan 29. Review.

PMID:
18227842
2.

Genotoxicity of retroviral integration in hematopoietic cells.

Nienhuis AW, Dunbar CE, Sorrentino BP.

Mol Ther. 2006 Jun;13(6):1031-49. Epub 2006 Apr 19. Review.

PMID:
16624621
3.

Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.

Goyama S, Kurokawa M.

Cancer Sci. 2009 Jun;100(6):990-5. doi: 10.1111/j.1349-7006.2009.01152.x. Epub 2009 Mar 9. Review.

PMID:
19385966
4.
5.

Leukemogenesis of the EVI1/MEL1 gene family.

Morishita K.

Int J Hematol. 2007 May;85(4):279-86. Review.

PMID:
17483069
6.

The role of EVI1 in normal and leukemic cells.

Buonamici S, Chakraborty S, Senyuk V, Nucifora G.

Blood Cells Mol Dis. 2003 Sep-Oct;31(2):206-12. Review.

PMID:
12972028
7.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

8.
9.

The EVI1 gene in myeloid leukemia.

Nucifora G.

Leukemia. 1997 Dec;11(12):2022-31. Review.

PMID:
9447815
10.

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

Wieser R.

Gene. 2007 Jul 15;396(2):346-57. Epub 2007 Apr 20. Review.

PMID:
17507183
12.

[Development and application of gene therapy technologies].

Ozawa K.

Uirusu. 2004 Jun;54(1):49-57. Review. Japanese.

13.

Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia.

Lopingco MC, Perkins AS.

Curr Top Microbiol Immunol. 1996;211:211-22. Review.

PMID:
8585952
14.

The role of EVI1 in myeloid malignancies.

Glass C, Wilson M, Gonzalez R, Zhang Y, Perkins AS.

Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):67-76. doi: 10.1016/j.bcmd.2014.01.002. Epub 2014 Feb 1. Review.

PMID:
24495476
15.
16.

EVI1 and hematopoietic disorders: history and perspectives.

Nucifora G, Laricchia-Robbio L, Senyuk V.

Gene. 2006 Mar 1;368:1-11. Epub 2005 Nov 28. Review.

PMID:
16314052
17.

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Baum C, von Kalle C, Staal FJ, Li Z, Fehse B, Schmidt M, Weerkamp F, Karlsson S, Wagemaker G, Williams DA.

Mol Ther. 2004 Jan;9(1):5-13. Review.

PMID:
14741772
18.

Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.

Kataoka K, Kurokawa M.

Cancer Sci. 2012 Aug;103(8):1371-7. doi: 10.1111/j.1349-7006.2012.02303.x. Epub 2012 May 18. Review.

PMID:
22494115
19.

Concise review: managing genotoxicity in the therapeutic modification of stem cells.

Baum C, Modlich U, Göhring G, Schlegelberger B.

Stem Cells. 2011 Oct;29(10):1479-84. doi: 10.1002/stem.716. Review.

20.

[Advances in the study of Evi1 and mds1 genes].

Xu K, Wang L, Hao Y.

Zhonghua Xue Ye Xue Za Zhi. 1999 Jun;20(6):331-3. Review. Chinese. No abstract available.

PMID:
11721391
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk